Introduction
The COVID-19 pandemic required rapid adaptation of multidisciplinary tumor board conferences to a virtual setting; however, there are few data describing the benefits and challenges of using such a platform.
Methods
An anonymous quality improvement survey was sent to caregivers who participate in tumor board meetings at a large academic institution. Individuals who had experience with both in-person and virtual tumor boards were included. Participants answered questions pertaining to the relative strengths and weaknesses of in-person and virtual settings.
Results
A total of 335 responses (23.3% response rate) were recorded and 253 met inclusion criteria. Twenty-five respondents (9.9%) were trainees and the remainder had completed training, the majority of whom (n = 86 [37.7%]) had been in practice for more than 16 years. The most common responders were surgeons, radiologists, and nurses (19.0%, 16.2%, and 14.6%, respectively). Colorectal, breast, and liver (18.6%, 17.0%, and 13.0%, respectively) were the most commonly attended meetings. Benefits of a virtual platform included greater ability to participate in off-site meetings, ease of attaining CME credit, and improved viewing of imaging. Significant challenges related to the virtual platform included a lack of networking opportunities, difficulty hearing, and inability to see the speaker. Respondents reported that strong internet connectivity, engaged participation from all disciplines, and strong leadership and organization of the meetings were critical for success.
Conclusions
The implementation of virtual tumor board meetings due to COVID-19 has been associated with numerous challenges. However, improving several key aspects of these meetings can improve participant satisfaction and ensure excellent patient care.